Renalogic partners with plans to manage the risks associated with Chronic Kidney Disease (CKD)and dialysis, which provides protection, cost savings, and cost avoidance in a highly dysfunctional market. Our proactive approach brings industry-leading results for managing massive risk.

Renalogic puts an end to surprise dialysis claims and emergency start dialysis with a valued collection of services led by CareINSIGHTS.ai, our market-leading artificial intelligence and proven intervention program. Our innovative data modeling can identify plan members, even those not yet diagnosed with CKD, who will progress to dialysis within the next 24 months. By identifying future cost spikes and plan use, we manage what others often cannot see. Every chronic condition leading to End-Stage Renal Disease (ESRD) is manageable and even preventable when identified early.

Our Kidney Dialysis Avoidance Program (KDAP) addresses the highest claims cost cohorts with a proven "One Size Fits One" intervention. KDAP provides intensive clinical intervention by specially trained nurses to slow, stop, and even reverse CKD progression.

Our proven, proprietary Cost Containment repricing methodology provides more protection with the industry's most defensible plan design, including document review and appeals support. Clients save 78 percent net on dialysis claims costs. Recent court rulings validated the Renalogic plan design as a safe harbor for repricing dialysis claims and protection against a multiple of Medicare (MoM) repricing vulnerability. Our Cost Containment comes with the added value of our Member Advocacy Program (MAPS), an advocacy and educational program which empowers members for better outcomes at no additional charge.

Only Renalogic is Identifying and proactively managing massive CKD and dialysis risks for health plans. The result is cost savings and cost avoidance for plans and healthier outcomes for members.

Learn more at renalogic.com.

Renalogic in the News
RL TEST 3.png
Jeb Dunkelberger, Richard Jones, Rose Maljanian, and Ryan McDevitt join advisory board for industry leading dialysis cost containment company
October 28, 2021
RL TEST 3.png
Leading cost-containment solution for chronic kidney disease attracts top commercial, financial, and technical talent
August 25, 2021
RL TEST 3.png
Industry veteran to drive growth for pioneering dialysis risk management and cost containment company
August 10, 2021
RL TEST 3.png
Phoenix, AZ —March 10, 2021— Renalogic, Inc., the industry leader in dialysis risk management and cost containment, announced today that John R. Christiansen has joined the company as Executive Vice President of Legal Risk and Strategy. The announcement comes on the heels of their recently announced partnership with Carrick Capital Partners, which will build on Renalogic’s market leading position.
March 10, 2021
Carrick Logo TM.jpg
Leader in dialysis risk management and cost containment poised for accelerated growth and service offering expansion
March 3, 2021
About Carrick Capital Partners
Who We Are
A firm of enterprise software, SaaS, and technology enabled services investors and operating executives with substantial experience founding, scaling, and optimizing market leading businesses.
Our Approach
We work with management to identify and improve critical areas of their business - focusing on the priorities that align with our experiences and that will deliver the highest strategic impact in both the short-term and long-run.
Why We Are Different
We have a concentrated number of companies in our portfolio so that we can build substantial relationships with each management team and ensure our firm's commitment to each company's goals.